Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human α-l-iduronidase gene
Open Access
- 30 June 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (6) , 866-875
- https://doi.org/10.1016/j.ymthe.2004.03.011
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Gene Transfer Strategies for Correction of Lysosomal Storage DisordersActa Haematologica, 2003
- Gene Therapy with Virus Vectors for specific Disease of the Nervous SystemPublished by Elsevier ,2003
- Murine Mucopolysaccharidosis VII: Impact of Therapies on the Phenotype, Clinical Course, and Pathology in a Model of a Lysosomal Storage DiseasePediatric and Developmental Pathology, 2001
- Enzyme Replacement Therapy in Feline Mucopolysaccharidosis IMolecular Genetics and Metabolism, 2001
- Hurler Syndrome: II. Outcome of HLA-Genotypically Identical Sibling and HLA-Haploidentical Related Donor Bone Marrow Transplantation in Fifty-Four ChildrenBlood, 1998
- Long-Term and High-Dose Trials of Enzyme Replacement Therapy in the Canine Model of Mucopolysaccharidosis IBiochemical and Molecular Medicine, 1996
- Molecular genetics of muccpolysaccharidosis type I: Diagnostic, clinical, and biological implicationsHuman Mutation, 1995
- Long‐term outcome of Hurler syndrome following bone marrow transplantationAmerican Journal of Medical Genetics, 1993
- REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATIONThe Lancet, 1981
- Hurler and Hunter Syndromes: Mutual Correction of the Defect in Cultured FibroblastsScience, 1968